Utah Medical Products (UTMD 0.41%), a developer and manufacturer of specialty medical devices for women’s health, neonatal, and critical care markets, released its second quarter 2025 earnings on July 24, 2025. The company reported a 4.3% decrease in GAAP revenue compared to the prior year, as expected, in line with management’s projections. Revenue for the period was $9.95 million, largely affected by the anticipated drop in sales to its biggest biopharma equipment customer, PendoTECH. Diluted earnings per ...